About us

Kedrion Biopharma is an international biopharmaceutical company based in Italy that collects and fractionates plasma to produce and distribute worldwide plasma-derived products for the prevention and treatment of rare and debilitating diseases and conditions such as Hemophilia, Primary Immunodeficiencies and Rh sensitization.

Kedrion operates in Turkey through its subsidiary Kedrion Betaphar offering a portfolio of medicines and licensed products to treat Immunology, Neurology, Hematology, Intensive care and Transplantation patients.


Read more

PRODUCT PORTFOLIO

As a result of its solid and successful experience as partner with the Italian Health System, its significant expansion into international operations and a fundamental commitment to research and development, Kedrion’s line of plasma-derived products is broad and diverse.

With treatments for many rare and debilitating diseases and conditions from hemolytic disease in newborns to immune deficiencies to hemophilia, Kedrion offers a wide and expanding array of treatments and therapies.


RARE DISEASES

MOTHER AND CHILD HEALTH

INTENSIVE CARE & TRANSPLANTATION

Therapeutic AREAS

Our continuing commitment to research, development and innovation aims to meet the therapeutic needs of the largest number of patients living with a rare disease or debilitating condition across the world.



https://www.kedrion.com.tr/wp-content/uploads/2021/07/kd13_about-us_box.jpg
Rare Diseases
This Area focuses on diseases such as Hemophilia, Von Willebrand Disease, Immune System Disorders and Neurology.
CONTINUE READING
https://www.kedrion.com.tr/wp-content/uploads/2021/06/kd23_therapies-mother-and-child.jpg
Mother and Child Health
This Area focuses on Hemolytic Disease of the Fetus and Newborn and on vertical (mother to child) transmission of Hepatitis B.
CONTINUE READING
https://www.kedrion.com.tr/wp-content/uploads/2021/06/kd54_intensive-care-1.jpg
Intensive Care and Transplantation
This Area focuses on Hepatitis B, Human Albumin, Antithrombin, Prothrombin Complex Coagulation Factors (PCC) and Rabies.
CONTINUE READING

News

26/04/2021
KEDRION SUPPORTS WORLD PRIMARY IMMUNODEFICIENCY WEEK
Early diagnosis and access to treatment to improve the quality of life of patients
CONTINUE READING
15/04/2021
WORLD HEMOPHILIA DAY 2021, KEDRION ALONGSIDE PATIENTS
Today, more than ever, the company is close to those who are in a vulnerable condition
CONTINUE READING
07/04/2021
RH&LIFE, FIRST SUBJECT INCLUDED IN THE STUDY
Two hundred pregnant women to be enrolled over five countries
CONTINUE READING
01/04/2021
Updates on Anti-Covid treatment developed by Kamada and Kedrion
Top-line results announced from the phase 1/2 Clinical Trial in Israel
CONTINUE READING

Download area

Find all the documents you might need in one practical download area.



View documents


Contact us

Thank you for your interest in Kedrion. You can contact us by submitting a message form. Please follow the links below according to your interests or subject of inquiry.



MARKETING & GENERAL INQUIRIES
For commercial information

EN: Kedrion In The World
Policy *
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MEDICAL INFORMATION
Contact the Medical Information Request Form below to learn more.

EN: Medical scientific information
Qualification *
If medical, please indicate your specialty
If patient, please report the contact details of the doctor or the treating center
Please do not use this field to report adverse events (side effects) or product complaints: In the event of a complaint, please contact the Quality Assurance department. In case of adverse reactions please contact the Pharmacovigilance.
Privacy Policy *
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PHARMACOVIGILANCE
How to, and to whom, report an adverse reaction
If you wish to directly notify Kedrion about a suspected adverse reaction related to our drugs, please fill in the form below:

EN: Pharmacovigilance
Qualification *
Gender (M/F)
Has the adverse event stopped?
How bad was the adverse event?
How is the adverse event now?
In processing your personal data, Kedrion will fully comply with internationally recognized standards of data protection. In doing so, Kedrion ensures compliance of its staff with strict standards of security and confidentiality.
Privacy *
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.